Terms: = Leukemia AND CNTRL, CEP1, CEP110, 11064, ENSG00000119397
15 results:
1. Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.
Tan KW; Zhu YY; Qiu QC; Wang M; Shen HJ; Huang SM; Cao HY; Wan CL; Li YY; Dai HP; Xue SL
Ann Hematol; 2023 Sep; 102(9):2397-2402. PubMed ID: 37103615
[TBL] [Abstract] [Full Text] [Related]
2. Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan.
Hsu YC; Yu CH; Chen YM; Roberts KG; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Chang HH; Lin DT; Lin SW; Lin ZS; Chiu WT; Chang CC; Ho BC; Mullighan CG; Yu SL; Yang YL
Sci Rep; 2021 Mar; 11(1):5802. PubMed ID: 33707599
[TBL] [Abstract] [Full Text] [Related]
3. Myeloid/lymphoid neoplasm with cep110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.
Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R
Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601
[No Abstract] [Full Text] [Related]
4. Targeted therapy and disease monitoring in cntrl-FGFR1-driven leukaemia.
Brown LM; Bartolo RC; Davidson NM; Schmidt B; Brooks I; Challis J; Petrovic V; Khuong-Quang DA; Mechinaud F; Khaw SL; Majewski IJ; Oshlack A; Ekert PG
Pediatr Blood Cancer; 2019 Oct; 66(10):e27897. PubMed ID: 31250523
[TBL] [Abstract] [Full Text] [Related]
5. Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and
Wehrli M; Oppliger Leibundgut E; Gattiker HH; Manz MG; Müller AM; Goede JS
Oncologist; 2017 Apr; 22(4):480-483. PubMed ID: 28242791
[TBL] [Abstract] [Full Text] [Related]
6. [8p11 myeloproliferative syndrome with cep110-FGFR1 fusion in a patient].
Chao H; Chen S; Zhou M; Lu X; Zhang X; Pan J; Wu C; Zhang R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):679-82. PubMed ID: 26418991
[TBL] [Abstract] [Full Text] [Related]
7. Dysregulated signaling pathways in the development of cntrl-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models.
Ren M; Qin H; Kitamura E; Cowell JK
Blood; 2013 Aug; 122(6):1007-16. PubMed ID: 23777766
[TBL] [Abstract] [Full Text] [Related]
8. Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.
Hu S; He Y; Zhu X; Li J; He H
Pediatr Hematol Oncol; 2011 Mar; 28(2):140-6. PubMed ID: 21214407
[TBL] [Abstract] [Full Text] [Related]
9. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), cep110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
[TBL] [Abstract] [Full Text] [Related]
10. Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia.
Xu W; Li JY; Fan L; Chen LJ; Qiu HR; Qiu HX; Lu H
Int J Lab Hematol; 2009 Jun; 31(3):338-43. PubMed ID: 18284415
[TBL] [Abstract] [Full Text] [Related]
11. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and cep110-FGFR1 fusion: report of a new case and review of the literature.
Mozziconacci MJ; Carbuccia N; Prebet T; Charbonnier A; Murati A; Vey N; Chaffanet M; Birnbaum D
Leuk Res; 2008 Aug; 32(8):1304-8. PubMed ID: 18096225
[TBL] [Abstract] [Full Text] [Related]
12. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
Macdonald D; Reiter A; Cross NC
Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
[TBL] [Abstract] [Full Text] [Related]
13. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
[TBL] [Abstract] [Full Text] [Related]
14. Identification of four new translocations involving FGFR1 in myeloid disorders.
Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
[TBL] [Abstract] [Full Text] [Related]
15. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
[TBL] [Abstract] [Full Text] [Related]